|
|
Blood, 1 June 2004, Vol. 103, No. 11, pp. 4317-4321.
Prepublished online as a Blood First Edition Paper on February 24, 2004; DOI 10.1182/blood-2004-01-0192.

Submitted January 20, 2004
Accepted February 11, 2004
The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis
Carmela Lanzara, Antonella Roetto, Filomena Daraio, Silvain Rivard, Romina Ficarella, Hervey Simard, Timothy Cox, Mario Cazzola, Alberto Piperno, Anne-Paule Gimenez-Roqueplo, Paola Grammatico, Stefano Volinia, Paolo Gasparini, and Clara Camaschella*
Genetica Medica Dipartimento di Patologia generale, II Universita di Napoli, Napoli, Italy; Tigem (Telethon Institute of genetics and Medicine, Napoli, Italy
Dipartimento di Scienze Cliniche e biologiche Azienda Ospedaliera San Luigi Gonzaga, Universita di Torino, Orbassano, Torino, Italy
Sagen Pharma, Ville de Saguenay, Quebec, Canada
Genetica Medica Dipartimento di Patologia generale, II Universita di Napoli, Napoli, Italy
Department of Medicine., University of Cambridge, Cambridge, United Kingdom
Dipartimento di Medicina Interna, IRCCS Policlinico San Matteo, Pavia, Italy
Clinica Medica, Azienda Ospedaliera San Gerardo, Monza, Italy
Departement de Genetique Moleculaire, Hopital Europeen Georges Pompidou, Paris, France
genetica medica, Dipartimento di Medicina Sperimentale e Patologia, Universita La Sapienza, Roma, Italy
Dipartimento di Morfologia ed Embriologia, Laboratorio di Genomica Funzionale, Universita degli Studi di Ferrara, Ferrara, Italy
* Corresponding author; email: clara.camaschella{at}unito.it.
Juvenile or type 2 hemochromatosis (JH) is transmitted as a recessive trait that leads to severe iron overload and organ damage typically before 30 years. Linkage to a locus on chromosome 1q has been found in most patients with JH. The recently identified causal gene encodes hemojuvelin, a protein with a proposed crucial role in iron metabolism. A second, rare type of JH, with clinical expression identical to the 1q-linked form, is due to inactivation of hepcidin, the key regulator of iron homeostasis. Here we report the spectrum of mutations of the hemojuvelin gene (HJV) in 34 patients who did not show hepcidin mutations. This represents the largest cohort of JH patients worldwide collected. We identified 17 different (16 novel) mutations of HJV, both at the homozygous and at the compound heterozygous state. Mutations either generate premature termination codons or were missense substitutions, affecting highly conserved residues, relevant to the protein structure and/or function.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Y. Lok, A. T. Merryweather-Clarke, V. Viprakasit, Y. Chinthammitr, S. Srichairatanakool, C. Limwongse, D. Oleesky, A. J. Robins, J. Hudson, P. Wai, et al.
Iron overload in the Asian community
Blood,
July 2, 2009;
114(1):
20 - 25.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Nagayoshi, M. Nakayama, S. Suzuki, J. Hokamaki, H. Shimomura, K. Tsujita, M. Fukuda, T. Yamashita, Y. Nakamura, S. Sugiyama, et al.
A Q312X mutation in the hemojuvelin gene is associated with cardiomyopathy due to juvenile haemochromatosis
Eur J Heart Fail,
October 1, 2008;
10(10):
1001 - 1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Silvestri, A. Pagani, and C. Camaschella
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Blood,
January 15, 2008;
111(2):
924 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Fleming
The Regulation of Hepcidin and Its Effects on Systemic and Cellular Iron Metabolism
Hematology,
January 1, 2008;
2008(1):
151 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Silvestri, A. Pagani, C. Fazi, G. Gerardi, S. Levi, P. Arosio, and C. Camaschella
Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis
Blood,
May 15, 2007;
109(10):
4503 - 4510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Aguilar-Martinez, C. Y. Lok, S. Cunat, E. Cadet, K. Robson, and J. Rochette
Juvenile hemochromatosis caused by a novel combination of hemojuvelin G320V/R176C mutations in a 5-year old girl
Haematologica,
March 1, 2007;
92(3):
421 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rideau, B. Mangeat, T. Matthes, D. Trono, and P. Beris
Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis
Haematologica,
January 1, 2007;
92(1):
127 - 128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K Mueller, T. Yamashita, G. Schaffar, and R. Mueller
The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system
Phil Trans R Soc B,
September 29, 2006;
361(1473):
1513 - 1529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kuninger, R. Kuns-Hashimoto, R. Kuzmickas, and P. Rotwein
Complex biosynthesis of the muscle-enriched iron regulator RGMc
J. Cell Sci.,
August 15, 2006;
119(16):
3273 - 3283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Swinkels, M. C.H. Janssen, J. Bergmans, and J. J.M. Marx
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Clin. Chem.,
June 1, 2006;
52(6):
950 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Camaschella
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
Blood,
December 1, 2005;
106(12):
3710 - 3717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Porto, A. Roetto, F. Daraio, J. P. Pinto, S. Almeida, C. Bacelar, E. Nemeth, T. Ganz, and C. Camaschella
A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state transcription but fails to up-regulate hepcidin levels by iron
Blood,
October 15, 2005;
106(8):
2922 - 2923.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-S. Zhang, A. P. West Jr., A. E. Wyman, P. J. Bjorkman, and C. A. Enns
Interaction of Hemojuvelin with Neogenin Results in Iron Accumulation in Human Embryonic Kidney 293 Cells
J. Biol. Chem.,
October 7, 2005;
280(40):
33885 - 33894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Nemeth, A. Roetto, G. Garozzo, T. Ganz, and C. Camaschella
Hepcidin is decreased in TFR2 hemochromatosis
Blood,
February 15, 2005;
105(4):
1803 - 1806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Janosi, H. Andrikovics, K. Vas, A. Bors, M. Hubay, Z. Sapi, and A. Tordai
Homozygosity for a novel nonsense mutation (G66X) of the HJV gene causes severe juvenile hemochromatosis with fatal cardiomyopathy
Blood,
January 1, 2005;
105(1):
432 - 432.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Krijt, M. Vokurka, K.-T. Chang, and E. Necas
Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin
Blood,
December 15, 2004;
104(13):
4308 - 4310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. van Heyningen and P. L. Yeyati
Mechanisms of non-Mendelian inheritance in genetic disease
Hum. Mol. Genet.,
October 1, 2004;
13(suppl_2):
R225 - R233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K J H Robson, A T Merryweather-Clarke, E Cadet, V Viprakasit, M G Zaahl, J J Pointon, D J Weatherall, and J Rochette
Recent advances in understanding haemochromatosis: a transition state
J. Med. Genet.,
October 1, 2004;
41(10):
721 - 730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Le Gac, V. Scotet, C. Ka, I. Gourlaouen, L. Bryckaert, S. Jacolot, C. Mura, and C. Ferec
The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype
Hum. Mol. Genet.,
September 1, 2004;
13(17):
1913 - 1918.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|